These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37183116)

  • 1. [Genetic tumour diagnostics and personalised medicine from a systems perspective].
    Schillinger G
    Z Evid Fortbild Qual Gesundhwes; 2023 Jun; 179():91-94. PubMed ID: 37183116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany.
    Kusch M; Labouvie H; Schiewer V; Talalaev N; Cwik JC; Bussmann S; Vaganian L; Gerlach AL; Dresen A; Cecon N; Salm S; Krieger T; Pfaff H; Lemmen C; Derendorf L; Stock S; Samel C; Hagemeier A; Hellmich M; Leicher B; Hültenschmidt G; Swoboda J; Haas P; Arning A; Göttel A; Schwickerath K; Graeven U; Houwaart S; Kerek-Bodden H; Krebs S; Muth C; Hecker C; Reiser M; Mauch C; Benner J; Schmidt G; Karlowsky C; Vimalanandan G; Matyschik L; Galonska L; Francke A; Osborne K; Nestle U; Bäumer M; Schmitz K; Wolf J; Hallek M
    BMC Health Serv Res; 2022 Apr; 22(1):543. PubMed ID: 35459202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline findings in patients with advanced malignancies screened with paired blood-tumour testing for personalised treatment approaches.
    Roggia C; Armeanu-Ebinger S; Gschwind A; Seibel-Kelemen O; Hertler S; Faust U; Liebmann A; Haack TB; Neumann M; Bonzheim I; Forschner A; Kopp HG; Herster F; Hartkopf A; Bitzer M; Malek NP; Brecht IB; Ruhm K; Möller Y; Löwenheim H; Ossowski S; Rieß OH; Schroeder C
    Eur J Cancer; 2023 Jan; 179():48-55. PubMed ID: 36495689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genomics medicine and oncology].
    Michielin O; Coukos G
    Praxis (Bern 1994); 2014 May; 103(10):591-6. PubMed ID: 24800772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalised medicine in veterinary oncology: one to cure just one.
    Klopfleisch R
    Vet J; 2015 Aug; 205(2):128-35. PubMed ID: 25641551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Promise and the Hype of 'Personalised Medicine'.
    Maughan T
    New Bioeth; 2017 Apr; 23(1):13-20. PubMed ID: 28517988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
    Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems.
    Normanno N; Apostolidis K; de Lorenzo F; Beer PA; Henderson R; Sullivan R; Biankin AV; Horgan D; Lawler M
    Semin Cancer Biol; 2022 Sep; 84():293-301. PubMed ID: 34389490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe.
    Wurcel V; Perche O; Lesteven D; Williams DA; Schäfer B; Hopley C; Jungwirth R; Postulka A; Pasmans R; Hermansson LL; Ott M; Glorioso V
    Public Health Genomics; 2016; 19(3):137-43. PubMed ID: 27237134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
    Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O
    Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
    Helland Å; Russnes HG; Fagereng GL; Al-Shibli K; Andersson Y; Berg T; Bjørge L; Blix E; Bjerkehagen B; Brabrand S; Cameron MG; Dalhaug A; Dietzel D; Dønnem T; Enerly E; Flobak Å; Fluge S; Gilje B; Gjertsen BT; Grønberg BH; Grønås K; Guren T; Hamre H; Haug Å; Heinrich D; Hjortland GO; Hovig E; Hovland R; Iversen AC; Janssen E; Kyte JA; von der Lippe Gythfeldt H; Lothe R; Lund JÅ; Meza-Zepeda L; Munthe-Kaas MC; Nguyen OTD; Niehusmann P; Nilsen H; Puco K; Ree AH; Riste TB; Semb K; Steinskog ESS; Stensvold A; Suhrke P; Tennøe Ø; Tjønnfjord GE; Vassbotn LJ; Aas E; Aasebø K; Tasken K; Smeland S
    J Transl Med; 2022 May; 20(1):225. PubMed ID: 35568909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics.
    Doig KD; Love CG; Conway T; Seleznev A; Ma D; Fellowes A; Blombery P; Fox SB
    BMC Med Genomics; 2022 Mar; 15(1):70. PubMed ID: 35346197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early technology assessment of using whole genome sequencing in personalized oncology.
    Simons M; Van De Ven M; Coupé V; Joore M; IJzerman M; Koffijberg E; Frederix G; Uyl-De Groot C; Cuppen E; Van Harten W; Retèl V
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):343-351. PubMed ID: 33910430
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology.
    Mela A; Rdzanek E; Tysarowski A; Sakowicz M; Jaroszyński J; Furtak-Niczyporuk M; Żurek G; Poniatowski ŁA; Jagielska B
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jan; 23(1):43-54. PubMed ID: 36437684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genomic medicine and infectious diseases].
    Fellay J
    Praxis (Bern 1994); 2014 May; 103(10):587-90. PubMed ID: 24800771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
    Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
    Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics.
    Singer F; Irmisch A; Toussaint NC; Grob L; Singer J; Thurnherr T; Beerenwinkel N; Levesque MP; Dummer R; Quagliata L; Rothschild SI; Wicki A; Beisel C; Stekhoven DJ
    BMC Med Inform Decis Mak; 2018 Oct; 18(1):89. PubMed ID: 30373609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'.
    Westphalen BC; Bokemeyer C; Büttner R; Fröhling S; Gaidzik VI; Glimm H; Hacker UT; Heinemann V; Illert AL; Keilholz U; Kindler T; Kirschner M; Schilling B; Siveke JT; Schroeder T; Tischler V; Wagner S; Weichert W; Zips D; Loges S;
    Eur J Cancer; 2020 Aug; 135():1-7. PubMed ID: 32521293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Architecture of a Precision Oncology Platform.
    Laganà A
    Adv Exp Med Biol; 2022; 1361():1-22. PubMed ID: 35230680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Precision oncology : How can high-quality healthcare remain affordable for all in the face of diagnostic and therapeutic costs?].
    Schlomm T; Rödiger T; Graalmann J
    Urologe A; 2021 Jan; 60(1):3-7. PubMed ID: 33315135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.